3odk
From Proteopedia
(Difference between revisions)
												
			
			| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
| ==Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution== | ==Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution== | ||
| - | <StructureSection load='3odk' size='340' side='right' caption='[[3odk]], [[Resolution|resolution]] 2.30Å' scene=''> | + | <StructureSection load='3odk' size='340' side='right'caption='[[3odk]], [[Resolution|resolution]] 2.30Å' scene=''> | 
| == Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3odk]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3odk]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ODK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3ODK FirstGlance]. <br> | 
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ODK:3-PYRIDIN-2-YL-1H-PYRAZOLE-5-CARBOXYLIC+ACID'>ODK</scene>, <scene name='pdbligand=PE4:2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL'>PE4</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> | 
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ODK:3-PYRIDIN-2-YL-1H-PYRAZOLE-5-CARBOXYLIC+ACID'>ODK</scene>, <scene name='pdbligand=PE4:2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL'>PE4</scene></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3odk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3odk OCA], [https://pdbe.org/3odk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3odk RCSB], [https://www.ebi.ac.uk/pdbsum/3odk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3odk ProSAT]</span></td></tr> | |
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
| </table> | </table> | ||
| == Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/PIN1_HUMAN PIN1_HUMAN] Essential PPIase that regulates mitosis presumably by interacting with NIMA and attenuating its mitosis-promoting activity. Displays a preference for an acidic residue N-terminal to the isomerized proline bond. Catalyzes pSer/Thr-Pro cis/trans isomerizations. Down-regulates kinase activity of BTK. Can transactivate multiple oncogenes and induce centrosome amplification, chromosome instability and cell transformation. Required for the efficient dephosphorylation and recycling of RAF1 after mitogen activation.<ref>PMID:15664191</ref> <ref>PMID:16644721</ref> <ref>PMID:21497122</ref>  | 
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ==See Also== | |
| - | + | *[[Peptidyl-prolyl cis-trans isomerase 3D structures|Peptidyl-prolyl cis-trans isomerase 3D structures]] | |
| == References == | == References == | ||
| <references/> | <references/> | ||
| Line 24: | Line 18: | ||
| </StructureSection> | </StructureSection> | ||
| [[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| - | [[Category:  | + | [[Category: Large Structures]] | 
| - | [[Category: Baker | + | [[Category: Baker L]] | 
| - | [[Category: Bryant | + | [[Category: Bryant CJ]] | 
| - | [[Category: Davis | + | [[Category: Davis BE]] | 
| - | [[Category: Dokurno | + | [[Category: Dokurno P]] | 
| - | [[Category: Fromont | + | [[Category: Fromont C]] | 
| - | [[Category: Matossova | + | [[Category: Matossova N]] | 
| - | [[Category: Moore | + | [[Category: Moore JD]] | 
| - | [[Category: Murray | + | [[Category: Murray JB]] | 
| - | [[Category: Northfield | + | [[Category: Northfield CJ]] | 
| - | [[Category: Nunns | + | [[Category: Nunns C]] | 
| - | [[Category: Oldfield | + | [[Category: Oldfield V]] | 
| - | [[Category: Potter | + | [[Category: Potter A]] | 
| - | [[Category: Ray | + | [[Category: Ray S]] | 
| - | [[Category: Richardson | + | [[Category: Richardson CM]] | 
| - | [[Category: Robinson | + | [[Category: Robinson D]] | 
| - | [[Category: Scrace | + | [[Category: Scrace SF]] | 
| - | [[Category: Surgenor | + | [[Category: Surgenor AE]] | 
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
| 
 | |||||||||||
Categories: Homo sapiens | Large Structures | Baker L | Bryant CJ | Davis BE | Dokurno P | Fromont C | Matossova N | Moore JD | Murray JB | Northfield CJ | Nunns C | Oldfield V | Potter A | Ray S | Richardson CM | Robinson D | Scrace SF | Surgenor AE
